🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very happy to join this important discussion to guide clinicians in the management of people with Cerebral amyloid angiopathy. Sharing experience and knowledge with experts worldwide is the way to improve the prognosis of our patients

A great presentation by Andreas Charidimou MD, PhD on diagnostic perspectives in CAA! #iCAAPerth2022

Improving healthcare one step at a time, fascinating talks about improving co-creation for digital health at the WeLL Symposium World eHealth Living Lab Niels H. Chavannes, MD, PhD

1/ #STROKE #OriginalResearch: Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome #AHAJournals ahajournals.org/doi/10.1161/ST… Kanishk Kaushik @Ellis_van_Etten

Our study on Iatrogenic CAA is now available ahead of print! iCAA is common in young CAA patients and present in 4% diagnosed with the Boston Criteria. Deep hemorrhages present in 1/6th of patients, other features were similar to sCAA bob siegerink Universiteit Leiden LUMC Leiden

📢🚨Iatrogenic CAA may be underrecognized and common in nonhereditary CAA patients <55 years. Check out this new paper and an accompanying editorial in the latest issue of Stroke!🧠🩸 pubmed.ncbi.nlm.nih.gov/37035915/ pubmed.ncbi.nlm.nih.gov/37035916/ Kanishk Kaushik Steven M. Greenberg MD, PhD Andreas Charidimou MD, PhD

In this issue of #StrokeAlert prof Wermer and I had an interesting talk about iatrogenic CAA. Nice way to start off your #ESOC2023!

ELAN trial shows no increased harm of early start of anticoagulation among acute ischemic stroke patients with an indication of lower stroke recurrence at 90 days.

Lots of nice sessions coming up now at #ESOC2023! Looking forward to talks by Gargi Banerjee David Seiffge Reinier van der Zwet

In our latest #BloggingStroke post, Thanh Lam "Lance" Tran discusses #Stroke article "Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery" ahajrnls.org/3pS0dvh Check out the article by Kanishk Kaushik et al. ahajrnls.org/3Ulpt7W @Ellis_van_Etten

We recently published 2(6%) cases with CAA and a history of RBC transfusions from a prospective cohort 1) Neurologists should ask patients about such a history 2) Experimental evidence is needed. Read our paper at lnkd.in/eNk7AAgV @Ellis_van_Etten @MariekeWermer

#ESOC2024 has started! Happy to be sharing the first update about the international registry for iatrogenic CAA - on view today! (Epidemiology & Riskfactors ID:757) Gargi Banerjee @SchreuderFloris Martina Göldlin @MariekeWermer iCAA ECR network CAA

DAY 1 : #CAAConference2024 is open with thought provoking talks on iatrogenic CAA and transmissible amyloid seeeding hypotheses. More to come!

Very exciting meeting indeed; I was surprised this morning at the high number of iatrogenic CAA patients now being followed!